A.I.R-e

  • DATABASE (2662)

  • ARTICLES (286)

    • DATABASE (2662)
    • ARTICLES (286)
  • Sort by
    • Relevance
    • Date

Francis Obirikorang completed a bachelor’s degree in materials engineering in 2006 at Kwame Nkrumah University of Science and Technology (KNUST) in Kumasi, Ghana.In 2008, Obirikorang started work as a technical writer at Esoko, a Ghanaian digital development agency in Accra, where he met web developer Michael Ocansey. Obirikorang left Esoko in 2010 and became lead technical writer for Corenett, a transactions processing management company. In 2013, he worked at digital advertising agency TXT Ghana as a business analyst until 2015.In January 2015, Obirikorang and Ocansey established their first startup Swappaholics Holdings in the British Virgin Islands. In 2016, the two friends also co-founded AgroCenta (Holdings) Limited in Mauritius with Obirikorang as CEO and Ocansey as CTO. Ocansey left the Swappaholics in 2016 to focus on building AgroCenta.Obirikorang still runs both companies as CEO and joined the global entrepreneur community Startup Grind in 2016 as chapter director of Kumasi, Ghana’s second-largest city.

Pierre Fillard is Chief Science Officer and co-founder of Therapixel, creator of AI-powered breast cancer screening and diagnosis software MammoScreen. At Therapixel, he previously held the positions of CEO and CTO. Before founding Therapixel, Fillard was a senior research scientist at INRIA (National Institute for Research in Digital Science and Technology), where he focused on medical imaging and image processing. He has also been a visiting lecturer at CPE Lyon, a research associate at the French Alternative Energies and Atomic Agencies Commission, a PhD candidate at INRIA, and a research assistant at the University of North Carolina. He has a diploma from the HEC School of Management, a master’s in science, mathematics and computer science from the Université Jean Monnet Saint-Etienne and a degree in engineering, computer science, and applied mathematics from the Ecole Supérieure de Chimie Physique Electronique de Lyon. 

Olivier Clatz is the French co-founder of AI medical diagnosis company Therapixel, creator of MammoScreen breast cancer screening and diagnosis tool. Prior to co-founding Therapixel, Clatz worked for six years as a research scientist at INRIA (National Institute for Research in Digital Science and Technology) based at the Sophia Antipolis technology park near Antibes, in the south of France. His later work with INRIA focused on exploiting machine learning algorithms for medical imaging processing. Prior to this, he was a research associate at Harvard Medical School, in the US. In 2006, he completed his PhD at INRIA on the concept of personalized medicine. Clatz also holds a PhD in philosophy from the Ecole des Mines de Paris, and a master's degree in applied mathematics from the Ecole Normale Supérieure Paris-Saclay. Currently, he works at the French Government’s Commissariat Générale pour l’Investissement managing the national program AI For Diagnostics. He left Therapixel in 2019.

Shannon Falconer graduated with a master’s in botany at the University of Vancouver in 2006. She also completed a PhD in biochemistry at The McMaster University in 2014. She went on to work as a postdoctoral researcher at Stanford University until 2016 when she decided to become the CEO and co-founder of biotech startup Because Animals. She also led the biotech’s R&D team to develop plant-based nutritional cookies and treats for dog and cats. Because Animals now aims to produce the world’s first cell-based cultured meat products for pets.

A graduate with a master’s in Management and Business Strategy from the ESSEC Business School Paris, Nathanael Faibis had worked for two years as a project manager in France, Kenya and Morocco for a pharmaceutical market research company Sanisphere. In 2012, he worked for Lazada in Vietnam and Indonesia before becoming the head of production and user experience of Lazada Southeast Asia. However, he left Lazada in March 2013 to rejoin Sanisphere in Jakarta as the country head and global head of data management. Finally in April 2014, he decided to set up an Indonesian health portal Alodokter.

Khaled Kasem graduated in Dentistry from Jordan University of Science and Technology. In 2004 he moved to Spain to enroll in a Master of Orthodontics degree at the University of Barcelona. Kasem has over 15 years of experience in his sector, he also undertook further studies in advanced orthodontic techniques. Since 2019 he’s Chief Orthodontist and co-founder of Impress, an invisible aligners company using a hybrid model of remote patients monitoring and in-person visits. The startup is regarded as one of the fastest-growing telemedicine companies in Europe.

Diliara Lupenko is the COO and co-founder of Impress, an invisible aligners company regarded as one of the fastest-growing telemedicine startups in Europe. Prior to Impress, Lupenko served for over eight years as COO and CFO of Aquaton, a bathroom furniture plant and a subsidiary of the ROCA Group. She also worked in the Transaction Service Group in KPMG, managing financial due diligence of over 100 targets, pre-sale preparation of vendors, and restructuring, amongst other tasks. Impress is not Lupenko’s first entrepreneurial experience. In 2013 she co-founded Style Me Up the first Russian marketplace for designers of jewelry and accessories.

Vladimir Lupenko is a professional accountant, serial entrepreneur and angel investor. Lupenko’s latest entrepreneurial project is Impress, an invisible aligners company using a hybrid model of remote patient monitoring and in-person visits. The startup, headquartered in Barcelona but operating in several European countries, is regarded as one of the fastest-growing telemedicine companies in Europe.Originally from Russia, Lupenko holds a master’s in Economics from the Plekhanov Russian University of Economics. In 2005 he studied Corporate Finance at the Vienna University of Business and Economics. His professional career started as a Consultant in KPMG Russia in 2005, which he left two years later. Since 2007 he is also the co-founder of FCG, a corporate finance and M&A advisory firm in Russia and since 2013 he is also the non-executive co-founder of CarPrice one of the largest second-hand car marketplaces in Russia and Japan. In 2015, he co-founded AKTIVO a technology-backed real estate platform in Russia.

Bao Chunjian graduated from the University of Science and Technology of China in 2006 with a master’s degree in Computer Science. He then joined Tencent where he worked for nine years on the R&D of major data-related technologies rising to the level of a T4 expert engineer (the highest title an engineer can achieve in Tencent).  In 2015, Bao Chunjian recruited a few former Tencent employees and founded a startup to help blue-collar workers find jobs but that business failed in 2016.  He then started Xiaoe Tech.

Wang Lianghu graduated from the Chinese University of Hong Kong with a master's degree in 2011. He then joined Tencent and worked as a T3-level engineer. During his four years at Tencent, he focused on the design and R&D of Qzone (a Myspace-like blogging platform). After leaving Tencent, he co-founded Xiaoe Tech in 2016.

Zeng Yongjun holds a master’s degree in computer science from the Central South University. Before co-founding Xiaoe Tech, he worked at Tencent as a T3 level engineer, focusing on the R&D of big data platforms and applications.

Yu Qianli graduated from Wuhan University with a bachelor's degree in mechanical manufacturing and automation in 2014. Before co-founding Xiaoe Tech in 2016, he worked on the R&D of Qzone at Tencent.

Born in Jiangxi Province in 1962, Yang Wenlong is a traditional Chinese pharmacist and senior economist. The MBA graduate from Cheung Kong Graduate School of Business ran a traditional Chinese medicine business from 1982 to 1987 in Zhangshu. He also founded the Jiangxi Kangmei Medical & Healthcare Co Ltd in 1998 and the Renhe Group in 2001.He is the chairman of Renhe Group and Dingdang Medicine Express. He is a member of the national committee of the Chinese People's Political Consultative Conference (CPPCC) and a member of the central committee of the China National Democratic Construction Association.

Xu Huansheng was born in 1979 and obtained an MBA from the National School of Development, Peking University. He founded Baidu’s smart hardware unit and Baidu Cloud during his four years at Baidu in the early 2010s. He co-founded Dingdang Medicine Express in 2014. He is now a senior partner at Feihe Dairy (Firmus), one of the biggest infant and toddler formula producers in China.

Harvard Law graduate Shinta Nurfauzia earned her bachelor's degree in law at Universitas Indonesia. After working as a banking and finance associate at Allen & Overy Indonesia, and as a law associate at Lubis, Santosa & Maramis, Nurfauzia received the prestigious Indonesia Endowment Fund For Education Scholarship to Harvard Law School. Post-Harvard, Nurfauzia worked as a consultant to the Indonesian government sustainability program (REDD+) before founding the healthcare platform Konsula. She started her first business at 14 years old, a pancake business, and then a luxury bag reseller business.After Konsula pivoted to health food company Lemonilo, Nurfauzia remained at the company. She is currently Lemonilo’s co-CEO, sharing the role with Ronald Wijaya.

Sorry, we couldn’t find any matches for “A.I.R-e”.

Your payment was not successful.

Please make sure you have entered your payment details correctly. Or try again in a few moments.

small logo

The discount code you entered is invalid

Please make sure you have entered your discount code correctly. Or try again in a few moments.

Download successful.

Your sample has been sent. Please check your email.

By accessing and using www.compasslist.com and all pages within the domain (the “Website”), You accept and agree to have read, understood, accepted and agreed to be bound by the Terms of Use and Privacy Policy in full. If you disagree with all or any part of these Terms of Use and Privacy Policy, please do not use or continue any further use of this website. You acknowledge that you are aware that this Website contains an archive of existing content as at 31 December 2021 and is not being actively managed. We are under no obligation to update the content on this Website and, accordingly, no new content or articles will be posted to the Website after 31 December 2021.